XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin Bull-Market Signal Amid $84,000 Resistance
Bitcoin is flashing a historically significant bull-market signal even as price stalls just below $84,000, with BTC trading at $82,648 on October 12, down rough...
Kraken to Launch in UAE After Full Regulatory Approval
The approval grants Kraken authorization to operate in the UAE under the country’s existing virtual asset regulatory framework.
Crypto ETFs Lose $1.22B in One Week Without a Green Session
Spot Bitcoin and Ethereum ETFs shed a combined $1. 22 billion in a single week, according to unconfirmed reports, with every trading session closing in the red.
Evernorth Nasdaq Debut October 12: What It Could Mean for XRP
Evernorth begins trading on Nasdaq today, October 12, under the ticker ETWN, marking the company’s public market debut after completing its merger with Armada A...
Aave USDG Rollover: 2.98% Yield, Borrowing Costs and Rewards
A governance proposal on Aave to roll over USDG principal tokens in February carries a stated implied annual yield of 2. 98%, but two variables complicate that...
Kraken Futures Maker Protection Holds: Why Canceled Orders May Execute
Kraken futures traders who cancel a limit order while it sits in a Maker Protection hold should not assume the cancellation has fully removed their exposure. A...
